Hemispherx falls on Ampligen delay

Hemispherx (AMEX:HEB) fell $0.20 (38%) to $0.32 on Wednesday after FDA extended the PDUFA date for an NDA for Ampligen to treat chronic fatigue syndrome by three months to May 25 from Feb. 25. The ext...